Ceribell (CBLL) CFO Scott Blumberg Sells 687 Shares at $11.58

Ceribell, Inc. (CBLL) insider Scott Blumberg, who is Chief Financial Officer and a director, reported a disposition of 687 shares of common stock on 08/25/2025 at a price of $11.58 per share.

Rhea-AI Filing Summary

Ceribell, Inc. (CBLL) insider Scott Blumberg, who is Chief Financial Officer and a director, reported a disposition of 687 shares of common stock on 08/25/2025 at a price of $11.58 per share. After the reported sale, Mr. Blumberg beneficially owned 119,374 shares. The Form 4 was signed by an attorney-in-fact on 08/27/2025. The filing lists no derivative transactions or additional explanations.

Insights

Securities Analyst

TL;DR: Routine small insider sale; no derivatives or other transactions reported.

The Form 4 documents a single non-derivative disposition of 687 shares at $11.58, leaving the reporting person with 119,374 shares. This is a straightforward disclosure required under Section 16; the filing contains no indication of planned trading programs or derivative activity. The transaction is clearly reported and properly executed by an attorney-in-fact, meeting filing formalities.

Corporate Governance Expert

TL;DR: Compliance-focused filing showing an officer/director sale; appears procedurally complete.

The report names Scott Blumberg as CFO and director and shows a single sale recorded with signature by an attorney-in-fact. The form includes the required ownership post-transaction and lacks any supplemental explanations or indicators of Rule 10b5-1 plans. From a governance and disclosure perspective, the filing fulfills statutory reporting requirements without additional detail.

Insider Trade Summary

Exercise Price or Tax Liability: 687 shares

Exercise Price or Tax Liability 1 txn

Insider Blumberg Scott

Role Chief Financial Officer

Type	Security	Shares	Price	Value
Exercise Price or Tax Liability	Common Stock	687	$11.58	$8K

Holdings After Transaction: Common Stock — 119,374 shares (Direct)

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What transaction did Scott Blumberg report on Form 4 for CBLL?

The Form 4 reports a disposition of 687 shares of Ceribell common stock on 08/25/2025 at $11.58 per share.

How many Ceribell (CBLL) shares does the reporting person own after the sale?

After the reported transaction, Scott Blumberg beneficially owned 119,374 shares.

What is Scott Blumberg's role at Ceribell as listed on the Form 4?

The Form 4 lists Scott Blumberg as a Director and the company's Chief Financial Officer.

Was a derivative transaction or Rule 10b5-1 plan disclosed in this Form 4?

No derivatives or any indication of a Rule 10b5-1 trading plan are disclosed in the form.

Who signed the Form 4 for Scott Blumberg and when?

The Form 4 was signed by Louisa Daniels, Attorney-in-Fact for Scott Blumberg on 08/27/2025.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 08/27/2025 - 11:42 AM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Blumberg Scott

(Last) (First) (Middle)

C/O CERIBELL, INC.

360 N. PASTORIA AVENUE

(Street)

SUNNYVALE CA 94085

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Ceribell, Inc. [ CBLL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

3. Date of Earliest Transaction (Month/Day/Year)
08/25/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/25/2025		F		687	D	$11.58	119,374	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

	/s/ Louisa Daniels, Attorney-in-Fact for Scott Blumberg	08/27/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.